TaoDao Medical Showcases Innovations at CUA 2024: Advancing Minimally Invasive Surgery with TaoLing® and TaoYun® Robotic Systems

From September 19 to 22, the Tianjin National Convention and Exhibition Center hosted the 31st Urological Academic Conference (abbreviated as CUA2024), jointly organized by the Chinese Medical Association and its Urology Branch. This congress gathered elite experts in the field of urology to jointly explore the latest frontiers of medical technology. On this prestigious stage, Tuodao Medical, a pioneer in domestic medical innovation, presented its two cutting-edge products—Tuoling^®Laparoscopic Surgical Robots and Tuoyun^®Prostate Biopsy Surgical Robot Makes a Spectacular Debut, infusing the conference with a strong technological flair and new perspectives on smart healthcare.

Academician Zhang Xu and Other Experts Visit Tuodao Medical

Tuoling^®The endoscopic surgical robot made its public debut at CUA 2024, immediately drawing widespread attention and high acclaim from experts and professors both within and outside the industry. Integrating cutting-edge technology with human-centered design, this surgical robot not only sparked strong interest among industry experts but also demonstrated significant advantages in surgical precision and operational smoothness through exceptional live demonstrations, highlighting Tuodao Medical’s profound technical expertise and robust development potential.

Tuoling^®The endoscopic surgical robot consists of a surgeon console, a patient-side surgical platform, and an image processing platform. Compared with traditional laparoscopic surgery or similar products, it offers the following advantages:

● Broader and more flexible surgical scope

154cm Ultrasonic Scalpel: Tuoling^®The ultrasonic scalpel, with a length of up to 54 cm, overcomes the challenge of energy attenuation, ensuring consistent length compatibility with other instruments and enhancing accessibility and synergy in complex pelvic surgeries and procedures involving patients with high BMI.

13 Degrees of Freedom in a Single Arm: Enhanced dexterity significantly reduces intraoperative collisions while expanding the surgical coverage area.

● Smarter Operations

Master Hand Two-Stage Force Pinch: Tuoling^®Features a dual-stage forcepinch function in the master hand, enabling reliable grasping and soft tissue protection to avoid soft tissue injury.

Pre-embedded Force Sensor: The robotic arm moves more smoothly and naturally, with precision and fluidity. Combined with high-precision master-slave control algorithms, it empowers surgeons to perform delicate maneuvers with ease, significantly enhancing the precision and safety of surgical procedures.

Multiple authoritative experts pointed out that Tuoling^®As a shining star in China’s domestic smart healthcare sector, it signals that Chinese medical technology is steadily advancing toward global leadership, setting new trends for industry development.

In the clinical practice of Jiangsu Province Hospital and the First Affiliated Hospital of Nanchang University, Tuoling^®Laparoscopic surgical robots have been successfully applied in high-difficulty procedures, including radical prostatectomy and partial nephrectomy. Their exceptional performance and stability have earned high recognition from industry authorities such as Professor Wang Zengjun and Professor Wang Gongxian. They unanimously agree that the robot demonstrates outstanding capabilities in minimizing surgical trauma, controlling intraoperative bleeding, and accelerating patient recovery, thereby setting a new benchmark for domestically produced surgical robots.

Experts Test Drive and Experience the Superior Performance of Tuoling

(The photo shows Professor Wang Gongxian, Clinical PI of Urology, at the First Affiliated Hospital of Nanchang University)

It is worth noting that Tuoling^®Since the launch of its clinical trial project in March this year, complex surgical cases across multiple specialties—including urology, general surgery, and gynecology—have been efficiently completed within just three months. The speed and efficiency of the project’s advancement far exceed industry standards, further solidifying Tuodao Medical’s leading position in the medical technology sector.

Meanwhile, Tuodao Medical’s other innovative product—Tuoyun^®The prostate biopsy surgical robot also shone at the CUA Congress. This intelligent device, specifically designed for the early diagnosis and treatment of prostate cancer, significantly enhances the precision and safety of biopsies through accurate puncture planning and coaxial biopsy needle technology. Its unique surgical path design and easy-to-maintain mechanical structure effectively reduce the risk of surgical infection. Combined with advanced features such as image elastic registration fusion, 3D ultrasound system integration, and automatic contouring, it greatly improves the efficiency and accuracy of prostate cancer diagnosis and treatment, offering patients earlier screening and more effective therapeutic options.

Looking ahead, Tuodao Medical will remain true to its original aspiration, continue to deepen its engagement in the field of medical technology, and drive the research, development, and application of more innovative products, guided by its mission to “make surgery simpler and life healthier.” With Tuoling^®In the Style of Tuo^®With the imminent launch of these products, Tuodao Medical will collaborate with medical institutions and experts both in China and abroad to jointly promote the vigorous development of China’s medical technology, contributing to the building of a Healthy China and the enhancement of global healthcare standards. We have every reason to believe that Tuodao Medical, with its superior products and services, will gradually move to the center of the global stage, showcasing the unique charm and remarkable achievements of intelligent manufacturing in China.